Skip to main content
Caplight Logo









Nurea

Nurea

Private
BèglesHealthcare & Life Scienceshttps://nurea-soft.com/

Last Round

Seed

Sep 9, 2024

Total Funding Raised

$4.56M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nurea is a health-tech company that develops AI-powered medical imaging software to aid in the diagnosis and monitoring of cardiovascular and neurovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical imaging softwareSaMDsoftware as a medical devicevascular imagingautomated segmentationmedical AIaortic aneurysmradiology AIclinical decision supportsurgical planningPACS integration3D reconstructionhealthtechlongitudinal monitoringAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurea Comparables

Compare Nurea with similar companies based on industry and business-model similarity.

Nurea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PrediSurge
84%
RapidAI
78%
Viz.ai
75%

Nurea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 9, 2024
SeedJun 30, 2022
GrantJun 2, 2020
GrantJul 4, 2019

Key People

Founding team and executive leadership

Florian Bernard

CEO

Executive Team

Romain LEGUAY

CTO

Executive Team

Nurea Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 151% MoM.

  • Jul 24, 2026

    Monthly visitors increased 116% MoM.

Nurea Filings

Explore SEC and related filing metadata, where available.

Nurea filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nurea's valuation, stock price, and market status.

Is Nurea a public or private company?

Nurea is a private company.

What is the current stock price of Nurea?

Nurea is a private company with no public stock price. No recent secondary market data is available.

How much is Nurea worth (valuation)?

Valuation information for Nurea is not publicly available.

Can I buy Nurea stock?

Nurea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nurea's last funding round?

Nurea's most recent funding round was Seed on September 9, 2024.

Who are the main investors in Nurea?

Key investors in Nurea include Bpifrance, Paris Business Angels, Techno'Start, EIT Health.

Will Nurea IPO soon?

No public IPO plans have been announced for Nurea.

How can I track Nurea secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nurea's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBègles
Employee Range16
Year Founded2018
Last FundingSep 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?